More Breakthroughs on Cancer Research

Source: 24/7 News

(New York, NY)  --  The FDA is approving a breakthrough cancer drug that could have a major impact on how doctors treat more than a dozen cancers.  

Dr. David Hyman, of Memorial Sloan Kettering in New York City, lead the research on the new drug called Larotrectinib [[ Larrow-trect-tin-nib ]].  

Dr. Hyman said patients saw tumors disappear often within days.  

He adds the new drug is based on genetics, including 17 different malignancies which includes lung and breast cancers. 


Mike Miller

Mike Miller

Want to know more about Mike Miller? Get their official bio, social pages & articles on 1150 WIMA! Read more

title

Content Goes Here